Chinese CDMO Asymchem expands footprint with deal to take over former Pfizer UK site
Chinese CDMO Asymchem expands footprint with deal to take over former Pfizer UK site zbecker Tue, 05/21/2024 - 16:57
Chinese CDMO Asymchem expands footprint with deal to take over former Pfizer UK site zbecker Tue, 05/21/2024 - 16:57
Incyte plots Delaware expansion as it looks to re-wed commercial, medical teams in its home state fkansteiner Tue, 05/21/2024 - 15:37
ASCO: Merck KGaA, Pfizer's Bavencio combo misses survival mark in crowded kidney cancer space aliu Tue, 05/21/2024 - 14:32
In pharma tax probe, Wyden puts Pfizer in hot seat with CEO letter zbecker Tue, 05/21/2024 - 14:17
AstraZeneca, on fast track of growth, sets revenue target at $80B by 2030 kdunleavy Tue, 05/21/2024 - 09:34
Lilly pads case for mirikizumab in its next potential indication in Crohn's disease fkansteiner Tue, 05/21/2024 - 08:58
Astellas, Yaskawa Electric Corporation ink pact to explore automated cell therapy production jkeenan Tue, 05/21/2024 - 08:35
Lab at center of Zantac saga claims GSK hid drug’s risks for decades zbecker Mon, 05/20/2024 - 18:56